Skip to main content

Advertisement

Log in

A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept

  • Letter to the Editors
  • Published:
Rheumatology International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Diaz JC, Vallejo S, Canas CA (2012) Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab. Rheumatol Int 32(10):3315–3317

    Google Scholar 

  2. Song IH, Heldmann F, Rudwaleit M, Listing J, Appel H, Braun J et al (2010) Different response to rituximab in tumor necrosis factor blocker-naive patients with active ankylosing spondylitis and in patients in whom tumor necrosis factor blockers have failed: a twenty-four-week clinical trial. Arthritis Rheum 62(5):1290–1297

    Article  CAS  PubMed  Google Scholar 

  3. Kiltz U, Heldmann F, Baraliakos X, Braun J (2012) Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition: are there alternatives? Curr Opin Rheumatol 24(3):252–260

    Article  CAS  PubMed  Google Scholar 

  4. Heldmann F, Dybowski F, Saracbasi-Zender E, Fendler C, Braun J (2010) Update on biologic therapy in the management of axial spondyloarthritis. Curr Rheumatol Rep 12(5):325–331

    Article  CAS  PubMed  Google Scholar 

  5. Costa MF, Said NR, Zimmermann B (2008) Drug-induced lupus due to anti-tumor necrosis factor alpha agents. Semin Arthritis Rheum 37(6):381–387

    Article  CAS  PubMed  Google Scholar 

  6. Sarzi-Puttini P, Atzeni F, Capsoni F, Lubrano E, Doria A (2005) Drug-induced lupus erythematosus. Autoimmunity 38(7):507–518

    Article  CAS  PubMed  Google Scholar 

  7. Williams EL, Gadola S, Edwards CJ (2009) Anti-TNF-induced lupus. Rheumatology (Oxford) 48(7):716–720

    Article  CAS  Google Scholar 

  8. De Bandt M, Sibilia J, Le Loet X, Prouzeau S, Fautrel B, Marcelli C et al (2005) Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey. Arthritis Res Ther 7(3):R545–R551

    Article  PubMed Central  PubMed  Google Scholar 

  9. Ramos-Casals M, Brito-Zeron P, Munoz S, Soria N, Galiana D, Bertolaccini L et al (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242–251

    Article  Google Scholar 

  10. Lin J, Ziring D, Desai S, Kim S, Wong M, Korin Y et al (2008) TNF alpha blockade in human diseases: an overview of efficacy and safety. Clin Immunol 126(1):13–30

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  11. Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR (2011) Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent. Inflamm Bowel Dis 17(1):99–104

    PubMed  Google Scholar 

  12. van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA (2006) Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level. Rheumatology (Oxford) 45(10):1317–1319

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Özgür Akgül.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akgül, Ö., Kılıç, G., Kılıç, E. et al. A patient with ankylosing spondylitis who developed infliximab-induced lupus and treated with etanercept. Rheumatol Int 34, 443–444 (2014). https://doi.org/10.1007/s00296-012-2617-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-012-2617-8

Keywords

Navigation